Total Clarity Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,217
| Closed | -$303K | – | 319 |
|
|
2025
Q1 | $303K | Hold |
2,217
| – | – | 0.1% | 193 |
|
|
2024
Q4 | $303K | Sell |
2,217
-150
| -6% | -$20.5K | 0.1% | 194 |
|
|
2024
Q3 | $273K | Sell |
2,367
-66
| -3% | -$7.61K | 0.09% | 203 |
|
|
2024
Q2 | $335K | Buy |
2,433
+100
| +4% | +$13.8K | 0.12% | 175 |
|
|
2024
Q1 | $322K | Buy |
2,333
+515
| +28% | +$71K | 0.11% | 195 |
|
|
2023
Q4 | $240K | Buy |
+1,818
| New | +$240K | 0.1% | 204 |
|
|
2020
Q4 | – | Sell |
-3,210
| Closed | -$309K | – | 151 |
|
|
2020
Q3 | $309K | Hold |
3,210
| – | – | 0.27% | 93 |
|
|
2020
Q2 | $392K | Hold |
3,210
| – | – | 0.36% | 80 |
|
|
2020
Q1 | $278K | Buy |
3,210
+50
| +2% | +$4.33K | 0.43% | 75 |
|
|
2019
Q4 | $340K | Buy |
+3,160
| New | +$340K | 0.26% | 83 |
|